
Consortium To Optimise World Use Of Artemisinin Combination Treatments For Malaria
11/18/09 • 2 min
Previous Episode

"ACT Consortum" Investigates Millions of Lives At Stake From Substandard, Degraded And Fake Anti-Malarial Drugs
The problem of artemisinin combination treatments (ACTs) in malaria which are ineffective because of poor storage, manufacture, or criminal counterfeiting was addressed in Nairobi at the 5th Multilateral Initiative On Malaria Pan African Malaria Conference by Harparkash Kaur of the London School of Hygiene and Tropical Medicine—a member of the recently-formed: ACT Consortium. After her talk she discussed her data and the efforts the consortium is making to resolve the issue with Peter Goodwin.
Next Episode

Malaria Elimination Prospects Are Good In Many Regions
London School of Hygiene and Tropical Medicine Audio News Malaria Elimination Prospects Are Good In Many Regions NAIROBI, KENYA:Geoffrey Targett Professor of Parasitology at the London School of Hygiene and Tropical Medicine and member of the international Malaria Elimination Group, told the 5th Multilateral Initiative on Malaria Pan African Malaria Conference in Nairobi why there are good prospects for eliminating malaria altogether from some regions in the near future in the quest ultimately for global eradication. He outlined his reasons for optimism to Peter Goodwin.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/london-school-of-hygiene-and-tropical-medicine-audio-news-lshtm-podcas-34911/consortium-to-optimise-world-use-of-artemisinin-combination-treatments-1277504"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to consortium to optimise world use of artemisinin combination treatments for malaria on goodpods" style="width: 225px" /> </a>
Copy